Bank of New York Mellon’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-23,601
| Closed | -$215K | – | 4469 |
|
|
2023
Q1 | $215K | Sell |
23,601
-224
| -0.9% | -$2.04K | ﹤0.01% | 3886 |
|
|
2022
Q4 | $280K | Sell |
23,825
-453
| -2% | -$5.32K | ﹤0.01% | 3825 |
|
|
2022
Q3 | $514K | Buy |
24,278
+2,109
| +10% | +$44.7K | ﹤0.01% | 3550 |
|
|
2022
Q2 | $538K | Buy |
22,169
+173
| +0.8% | +$4.2K | ﹤0.01% | 3543 |
|
|
2022
Q1 | $1.1M | Buy |
21,996
+204
| +0.9% | +$10.2K | ﹤0.01% | 3250 |
|
|
2021
Q4 | $1.53M | Sell |
21,792
-58
| -0.3% | -$4.07K | ﹤0.01% | 3147 |
|
|
2021
Q3 | $2.04M | Buy |
21,850
+1,793
| +9% | +$167K | ﹤0.01% | 2959 |
|
|
2021
Q2 | $2.02M | Sell |
20,057
-3,705
| -16% | -$372K | ﹤0.01% | 2973 |
|
|
2021
Q1 | $2.22M | Sell |
23,762
-822
| -3% | -$76.7K | ﹤0.01% | 2870 |
|
|
2020
Q4 | $2.03M | Buy |
24,584
+4,973
| +25% | +$410K | ﹤0.01% | 2836 |
|
|
2020
Q3 | $1.68M | Sell |
19,611
-1,663
| -8% | -$143K | ﹤0.01% | 2761 |
|
|
2020
Q2 | $1.98M | Buy |
21,274
+5,439
| +34% | +$506K | ﹤0.01% | 2685 |
|
|
2020
Q1 | $451K | Buy |
15,835
+10,432
| +193% | +$297K | ﹤0.01% | 3426 |
|
|
2019
Q4 | $224K | Hold |
5,403
| – | – | ﹤0.01% | 3881 |
|
|
2019
Q3 | $76K | Buy |
5,403
+190
| +4% | +$2.67K | ﹤0.01% | 4056 |
|
|
2019
Q2 | $183K | Buy |
5,213
+4,346
| +501% | +$153K | ﹤0.01% | 3930 |
|
|
2019
Q1 | $49K | Sell |
867
-194
| -18% | -$11K | ﹤0.01% | 4084 |
|
|
2018
Q4 | $51K | Buy |
+1,061
| New | +$51K | ﹤0.01% | 4053 |
|
|
2018
Q2 | – | Sell |
-2,370
| Closed | -$248K | – | 4308 |
|
|
2018
Q1 | $248K | Buy |
2,370
+87
| +4% | +$9.1K | ﹤0.01% | 3848 |
|
|
2017
Q4 | $293K | Buy |
2,283
+803
| +54% | +$103K | ﹤0.01% | 3795 |
|
|
2017
Q3 | $171K | Sell |
1,480
-5
| -0.3% | -$578 | ﹤0.01% | 3904 |
|
|
2017
Q2 | $193K | Buy |
+1,485
| New | +$193K | ﹤0.01% | 3910 |
|